WELCOME TO i 2 I world of Q&A

12,898 questions

50,077 answers

12 comments

476,747 users

Welcome to Nueracity Q&A, where you can ask questions and receive answers from other members of the community. Those who can ask or answer 100 i2I Questions are eligible to come to Malaysia, to participate in i2I workshop-2 Which will be held in langkawi Island, Malaysia on May 2017. Each question asked or answered would fetch 40 points. So to attend i 2 I two, one has to get about 4000 points. Question must have a minimum of 160 words and not exceeding 600 words. In-order to get the valid points, your question must be answered within 7 days, after that the question will be deleted from the system.

Although Brazil had threatened to bypass drug patents in the past, the country had always reached a last-minute agreement with drug manufacturers

0 votes
13 views
The move, the first time Brazil has bypassed a patent, comes a day after talks on the efavirenz drug broke down when the Brazilian government rejected Merck & Co.'s offer to sell the drug at a 30 percent discount, or $1.10 per pill, down from $1.57.

변95출장마사지1-2The country was seeking to purchase the drug at 65 cents a pill, the same price Thailand pays.

Silva said Brazil would consider overriding the patent of any drug sold at unfair prices. "Between our business and our health, we are going to take care of our health," he said after signing the decree.

Amy Rose, a spokeswoman for the Whitehouse Station, N.J.-based company, said earlier that Merck would be "profoundly disappointed if Brazil goes ahead with a compulsory license."

A compulsory license is a legal mechanism that allows a country to manufacture or buy generic versions of patented drugs while paying the patent holder only a small royalty.

Brazilian law and rules established under the World Trade Organization allow compulsory licenses in a health emergency or if the pharmaceutical industry uses abusive pricing.

After Thailand moved to override patents on three anti-AIDS drugs, including those made by Abbott Laboratories and Merck, the United States placed Thailand on a list of copyright violators.

In Thailand's capital of Bangkok, AIDS activists rallied outside the U.S. Embassy on Thursday to protest that decision, calling the Thai government's move to slash the cost of pricey U.S.-made AIDS drugs a "lifesaver."

The president of the U.S.-based AIDS Healthcare Foundation, Michael Weinstein, called Brazil's action a "victory," saying in a statement, "We salute the courage of countries such as Brazil, Thailand and Mexico who are fighting to ensure drug access for AIDS patients the world over.

"Drug companies will go down in defeat every time they place themselves in the way of justice for 구리출장안마 AIDS patients," he said.

But the U.S.-Brazil Business Council said the decision was a "major step backward" in intellectual property law and warned it could harm development.

"Brazil is working to attract investment in innovative industries ... and this move will likely cause investments to go elsewhere," the council said in a statement.

Although Brazil had threatened to bypass drug patents in the past, the country had always reached a last-minute agreement with drug manufacturers.

Brazil provides free AIDS drugs to anyone who needs them and manufactures generic versions of several drugs that were in production before Brazil enacted an intellectual property law in 1997 to join the WTO.

But as newer drugs have emerged, costs ballooned and health officials warned that without deep discounts, they would be forced to issue compulsory licenses.

Efavirenz is used by 75,000 of the 180,000 Brazilians who receive free AIDS drugs from the government. The drug currently costs about the government about $580 per patient per year.

"Although (Brazil) provides this drug free to about 75,000 people, the price is 136 percent higher than this lab (Merck) offers to Thailand," Health Minister Jose Gomes Temporao said, and the price "threatened the viability of the anti-AIDS program."

The Health Ministry says a generic version of efavirenz would save the government some $240 million between now and 2012, when Merck's patent expires.
asked Jun 13 by NOZAmee8104 (120 points)

Your answer

Your name to display (optional):
Privacy: Your email address will only be used for sending these notifications.
நியூ இரா சிட்டி கேள்வி மற்றும் பதில் வலைதலத் திற்கு வரவேற்கிறோம். , நீங்கள் உங்கள் கேள்விகளுக்கு மற்ற சமூக உறுப்பினர்களின் மூலமாக பதில்களை பெற முடியும். எவர் ஒருவர் 100 கேள்விகள் அல்லது 100 பதில்கள் கொடுக்கிறார்களோ அவர்கள் லங்காவி - மலேசியாவில் நடைபெறும் "ஐ 2 ஐ" பயிற்சி பட்டறையில் இலவசமாக*** கலந்து கொள்ள தகுதிபெறுகிறார்கள். "ஐ 2 ஐ" பயிற்சி பட்டறை மே - 2017 இல் நடைபெற உள்ளது. கேட்கப்படும் அல்லது பதிலளிக்கும் ஒவ்வொரு கேள்விக்கும் 40 மதிப்பெண்கள் வழங்கப்படும். முதலில் 4000 மதிப்பெண்கள் எடுக்கும் நபர் இலவசமாக*** "ஐ 2ஐ" பயிற்சி பட்டறையில் கலந்துகொள்ள வாய்ப்பு அளிக்கப்படும். நீங்கள் புள்ளிகள் பெற கேள்விகள் குறைந்தபட்சம் 160 வார்த்தைகள் மற்றும் 600 வார்த்தைகளுக்கு மிகாமல் . இருக்கவேண்டும். உங்கள் கேள்விகளுக்கு 7 நாட்களுக்குள் பதில் அளிக்கவில்லை என்றல், கேள்வி வலைத்தளத்தில் இருந்து நீக்கப்படும். *** இது ஒரு சில நிபந்தனைகளுக்கு உட்பட்டது
...